Serum anticholinergic activity and behavior following atropine sulfate administration in the rat

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 1, 1996, Pages 151-154

  O'Hare, Eugene ^a,b   Weldon, Derik T ^a,d   Bettin, Kris ^a   Cleary, James ^a,b   Mach JR , John R ^a,c  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

atropine sulfate; delirium; multiple schedule (FR FI); serum anticholinergic activity (SAA)

Indexed keywords

ATROPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICHOLINERGIC EFFECT; ARTICLE; CONTROLLED STUDY; DELIRIUM; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; RESPONSE TIME;

ANIMALS; ATROPINE; BEHAVIOR, ANIMAL; CHOLINERGIC ANTAGONISTS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE;

EID: 0031012901     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00172-4     Document Type: Article

References (16)

1. American Psychiatric Association DSM-IV. Diagnostic and statistical manual of mental disorders 4:1994;American Psychiatric Association, Washington DC. 124.
2. Brown J. H. Atropine, scopolamine, and other related antimuscarinic drugs. Gilman A. G., Rall T. W., Nies A. S., Taylor P. The pharmacological basis of therapeutics. 1990;150-165 Pergamon Press, New York.
3. Cleary J., Hittner J. M., Semotuk M. T., Mantyh P., O'Hare E. Beta Amyloid(1-40) effects on behavior and memory. Brain Res. 682:1995;69-74.
4. Cleary J., Nader M., Thompson T. Effects of imiprimine on responding reduced by methadone. Pharmacol. Biochem. Behav. 25:1986;149-153.
5. Francis J., Kapoor W. N. Delirium in hospitalized elderly. J. Gen. Intern. Med. 5:1990;65-78.
6. Itil T. M. Anticholinergic drug-induced sleep patterns in man. Psychopharmacologica (Berlin). 14:1969;383-393.
7. Leavitt M. L., Trzepacz P. T., Ciongoli K. Rat model of delirium. atropine dose-response relationships J. Neuropsychiatry Clin. Neurosci. 6:1994;279-284.
8. Longo V. G. Behavioral and electroencephalographic effects of atropine and related compounds. Pharmacol. Rev. 18:1966;965-996.
9. Mach J. R., Dysken M. W., Kuskowski M., Richelson E., Holden L., Jilk K. M. Serum anticholinergic activity in hospitalized older persons with delirium. a preliminary study J. Am. Geriatr. Soc. 43:1995;491-495.
10. Poling A., Cleary J., Berens K., Thompson T. Neuroleptics and learning. effects of haloperidol, molindone, mesoridazine and thioridazine on behavior of pigeons under a repeated acquisition procedure J. Pharmacol. Exp. Ther. 255:1990;1240-1245.
11. Seiden L. S., Dykstra L. A. Psychopharmacology. A biochemical and behavioral approach:1977;Van Nostrand Reinhold, New York.
12. Thompson T., Honor J., Verchota S., Cleary J. Interval and ratio reinforcement contingencies as determinants of methadone's effects. Pharmacol. Biochem. Behav. 21:1984;743-747.
13. Tune L., Carr S., Hoag E.et al. Anticholinergic effects of drugs commonly prescribed in the elderly. potential means for assessing risk of delirium Am. J. Psychiatry. 149:1992;1393-1394.
14. Tune L., Coyle J. T. Serum levels of anticholinergic drugs in the treatment of acute extrapyramidal side effects. Arch. Gen. Psychiatry. 37:1980;293-297.
15. Trzepacz P. T., Leavitt M. L., Ciongoli K. An animal model for delirium. Psychosomatics. 33:1992;404-415.
16. White R. P., Nash C. B., Westerbeke E. J., Possanza G. J. Phylogenetic comparison of central actions produced by different doses of atropine and hyoscine. Arch. Int. Pharmacodyn. 132:1961;349-363.